The Department of Health – Abu Dhabi (DoH) has announced a strategic collaboration with MSD to evaluate the feasibility of establishing an Abu Dhabi logistics hub. Located within the Health, Endurance, Longevity, and Medicine (HELM) Cluster, this planned facility is designed to streamline the distribution of a comprehensive portfolio of pharmaceutical products across diverse regional markets. By developing this infrastructure, the partnership aims to improve access to innovative treatments and provide the necessary framework for scaling medical solutions and health innovations throughout the Middle East and beyond.
H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH, stated: “Scientific breakthroughs are emerging faster than ever, yet their ability to improve lives ultimately depends on how quickly and safely they reach the patients who need them. Abu Dhabi built a fully integrated model for intelligent life sciences, connecting advanced research, population genomics, resilient infrastructure and world-class distribution pathways within a single connected ecosystem. MSD’s intention to establish its regional hub in Abu Dhabi reflects the strength of this environment and the emirate’s role as a trusted partner for global healthcare leaders. For patients across the region, this milestone brings life-saving therapies closer. For the world, it reinforces Abu Dhabi’s readiness to scale health innovation and impact globally.”
The announcement, made during Abu Dhabi’s participation at the BIO International Convention 2026, underscores the emirate’s role as a secure launch market for next-generation medical treatments. By integrating MSD’s global expertise with the local healthcare ecosystem, the Abu Dhabi logistics hub will facilitate the efficient delivery of medical solutions to various regional markets. Ashraf Mallak, Managing Director MSD Gulf Countries, Libya and Egypt, noted: “This planned collaboration reflects our shared ambition to strengthen healthcare systems across the region. By combining MSD’s global expertise with Abu Dhabi’s advanced ecosystem, we aim to enhance resilience and improve how innovation reaches patients.” This initiative continues to build upon the emirate’s focus on advanced research and population genomics to drive global health impact and ensure the robust movement of therapies through established distribution pathways.
